RxSight, Inc. (RXST)
Company Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.
It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery.
It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017.
RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Country | United States |
Founded | 1997 |
IPO Date | Jul 30, 2021 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 221 |
CEO | Dr. Ronald M. Kurtz M.D. |
Contact Details
Address:
100 Columbia Street, Suite 120 Aliso Viejo, California 92656 United States | |
Phone | 949-521-7822 |
Website | rxsight.com |
Stock Details
Ticker Symbol | RXST |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $16.00 |
CIK Code | 0001111485 |
CUSIP Number | 78349D107 |
ISIN Number | US78349D1072 |
Employer ID | 94-3268801 |
SIC Code | 3851 |
Key Executives
Name | Position |
---|---|
Dr. Ronald M. Kurtz M.D. | President, Chief Executive Officer and Director |
Shelley B. Thunen | Chief Financial Officer and Assistant Secretary |
Dr. Ilya Goldshleger Ph.D. | Chief Operating Officer |
Eric J. Weinberg | Chief Commercial Officer |
Rebecca Williston | Vice President of Accounting and Finance |
Matt Haller Ph.D. | Chief Technology Officer |
Steve Everly | Vice President of US Sales |
Roy Freeman | Vice President of Marketing |
Caroline Vaughn | Vice President of Human Resources |
Scott Gaines | Senior Vice President of Commercial Operations and Business Process |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 9, 2023 | 8-K | Current Report |
Dec 12, 2022 | 8-K | Current Report |
Nov 7, 2022 | 10-Q | Quarterly Report |
Nov 7, 2022 | 8-K | Current Report |
Aug 12, 2022 | EFFECT | Notice of Effectiveness |
Aug 12, 2022 | 424B5 | Filing |
Aug 8, 2022 | 8-K | Current Report |
Aug 8, 2022 | S-3 | Registration statement under Securities Act of 1933 |
Aug 8, 2022 | 10-Q | Quarterly Report |
Aug 8, 2022 | 8-K | Current Report |